PSEUDOMONAL BACTERAEMIA side effect
What is PSEUDOMONAL BACTERAEMIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PSEUDOMONAL BACTERAEMIA and Recently Reported Side Effects
PSEUDOMONAL BACTERAEMIA and 15 most Active Side Effect polls
PSEUDOMONAL BACTERAEMIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Invirase Side Effects Report #5585348-X
Pharmacist from UNITED STATES reported INVIRASE problem on Jan 02, 2008. Male patient, 42 years of age, weighting 92.59 lb, was treated with INVIRASE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, pseudomonal bacteraemia, sepsis syndrome, septic shock, . INVIRASE dosage: unknown. During the same period patient was treated with KALETRA, DIDANOSINE. Patient was hospitalized. Patient died on 11/05/2007.
Tygacil Side Effects Report #5598720-9
TYGACIL problem was reported by a Health Professional from SPAIN on Jan 14, 2008. Male patient, 78 years of age, was diagnosed with cellulitis and was treated with TYGACIL. After drug was administered, patient experienced the following problems/side effects: cardiac failure, pseudomonal bacteraemia, rash, . TYGACIL dosage: unknown. Patient died on 12/27/2007.
Revlimid Side Effects Report #5725729-4
Physician from UNITED STATES reported REVLIMID problem on Apr 14, 2008. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: escherichia infection, pseudomonal bacteraemia, . REVLIMID dosage: 10 MG, QD, ORAL. During the same period patient was treated with ADVAIR DISKUS, AVODART, CLARITIN, LUMIGAN, PEPCID COMPLETE, PRAVACHOL. Patient was hospitalized. Patient died on 04/20/2008.
Neulasta Side Effects Report #5306315-7
NEULASTA problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Female patient, weighting 144.2 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: muscular weakness, pseudomonal bacteraemia, soft tissue disorder, staphylococcal sepsis, . NEULASTA dosage: unknown. During the same period patient was treated with CYTOXAN, TAXOL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5644019-1
Health Professional from UNITED STATES reported REVLIMID problem on Nov 26, 2007. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, lung infection pseudomonal, pseudomonal bacteraemia, . REVLIMID dosage: 5 MG, DAILY FOR 21D/28D, ORAL; 10 MG, DAILY FOR 21D/28D, ORAL; 10 MG, ORAL. During the same period patient was treated with EXJADE, FOSAMAX PLUS D, LORATADINE, ASPIRIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5527912-X
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Nov 26, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, lung infection pseudomonal, pseudomonal bacteraemia, thrombocytopenia, upper respiratory tract infection, . REVLIMID dosage: 5MG DAILY FOR 21D/28D PO. During the same period patient was treated with EXJADE, FOSAMAX PLUS D, LORATADINE, ASPIRIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5644019-1
Pharmacist from UNITED STATES reported REVLIMID problem on Nov 26, 2007. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, lung infection pseudomonal, pseudomonal bacteraemia, . REVLIMID dosage: 5 MG, DAILY FOR 21D/28D, ORAL; 10 MG, DAILY FOR 21D/28D, ORAL; 10 MG, ORAL. During the same period patient was treated with EXJADE, FOSAMAX PLUS D, LORATADINE, ASPIRIN. Patient was hospitalized. Patient recovered.
Neulasta Side Effects Report #5324994-5
NEULASTA problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Female patient, weighting 144.2 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: dehydration, muscular weakness, pseudomonal bacteraemia, soft tissue disorder, staphylococcal sepsis, . NEULASTA dosage: unknown. During the same period patient was treated with CYTOXAN, TAXOL, ZOLADEX, PROCRIT. Patient was hospitalized. Patient recovered.